<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21047954</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>01</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-5514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>85</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of virology</Title>
                <ISOAbbreviation>J. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Complement opsonization enhances friend virus infection of B cells and thereby amplifies the virus-specific CD8+ T cell response.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1151-5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01821-10</ELocationID>
            <Abstract>
                <AbstractText>B cells are one of the targets of Friend virus (FV) infection, a well-established mouse model often used to study retroviral infections in vivo. Although B cells may be effective in stimulating cytotoxic T lymphocyte responses, studies involving their role in FV infection have mainly focused on neutralizing antibody production. Here we show that polyclonal activation of B cells promotes their infection with FV both in vitro and in vivo. Furthermore, we demonstrate that complement opsonization of Friend murine leukemia virus (F-MuLV) enhances infection of B cells, which correlates with increased potency of B cells to activate FV-specific CD8(+) T cells.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bila</LastName>
                    <ForeName>Custodio</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Virology, Innsbruck Medical University, Fritz-Pregl Str. 3, 6020 Innsbruck, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oberhauser</LastName>
                    <ForeName>Verena</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ammann</LastName>
                    <ForeName>Christoph G</ForeName>
                    <Initials>CG</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ejaz</LastName>
                    <ForeName>Asim</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huber</LastName>
                    <ForeName>Georg</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schimmer</LastName>
                    <ForeName>Simone</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Messer</LastName>
                    <ForeName>Ron</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pekna</LastName>
                    <ForeName>Marcela</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>von Laer</LastName>
                    <ForeName>Dorothee</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dittmer</LastName>
                    <ForeName>Ulf</ForeName>
                    <Initials>U</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hasenkrug</LastName>
                    <ForeName>Kim J</ForeName>
                    <Initials>KJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stoiber</LastName>
                    <ForeName>Heribert</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bánki</LastName>
                    <ForeName>Zoltán</ForeName>
                    <Initials>Z</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P 21508</GrantID>
                    <Agency>Austrian Science Fund FWF</Agency>
                    <Country>Austria</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>11</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Virol</MedlineTA>
            <NlmUniqueID>0113724</NlmUniqueID>
            <ISSNLinking>0022-538X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>9007-36-7</RegistryNumber>
                <NameOfSubstance UI="D003165">Complement System Proteins</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003165" MajorTopicYN="N">Complement System Proteins</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005622" MajorTopicYN="N">Friend murine leukemia virus</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>1</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21047954</ArticleId>
            <ArticleId IdType="pii">JVI.01821-10</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.01821-10</ArticleId>
            <ArticleId IdType="pmc">PMC3019994</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Top Microbiol Immunol. 2001;260:229-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11443876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2005 Sep;35(9):2691-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16094691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Immunol. 2004 Dec;25(12):659-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15530836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1998 Aug;72(8):6559-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9658100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Apr 1;174(7):3920-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15778347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Immunol. 2004 Dec;60(6):543-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15584965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2006 Mar 15;176(6):3498-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16517718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2006 Oct;36(10):2658-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16981182</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Biosci. 2007;12:1544-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17127401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2007 Jan 15;178(2):1086-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17202372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2008 Jan;82(1):408-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17959678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2009 Feb;5(2):e1000298</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19214214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009;4(7):e6105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19568424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2009 Oct 8;114(15):3199-207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19671923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2010 Apr 1;184(7):4006-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20194720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2010 Apr;6(4):e1000891</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20442876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2010 Jun;84(12):6082-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20375169</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Virol. 2001;146(3):507-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11338387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunol. 2001 Dec;13(12):1583-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11717199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2002 Aug;17(2):211-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12196292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2004 Mar 15;103(6):2046-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14630810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2004 Mar;20(3):293-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15030773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2004 Oct 15;173(8):4775-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15470016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 1976 Aug 15;18(2):189-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1085288</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 1979 Jun;62(6):1497-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">312351</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1993 Apr 1;81(7):1808-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8461467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 1993 Apr;92(1):106-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7682158</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Immunol. 1993 Aug;38(2):183-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8346417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 1994 Nov;24(11):2784-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7957570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 1996 Nov;70(11):7773-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8892898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1998 Mar 19;392(6673):245-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9521319</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>